Site US10035 — San Francisco, California

Site US10035 is a clinical research site located in San Francisco, California, United States 94143.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Site US10035 has participated in 2 clinical trials.

Therapeutic areas: Cytomegalovirus (CMV)-Positive Recipients, Allogeneic, Hematopoietic Cell Transplant (HCT), HER2 Amplified.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10035?

Site US10035 has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10035 conducted?

Site US10035 has 2 clinical trials on record. Their work covers Cytomegalovirus (CMV)-Positive Recipients, Allogeneic, Hematopoietic Cell Transplant (HCT), HER2 Amplified.

Is Site US10035 accredited by Crixeo Health?

Site US10035 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10035?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.